Palvella Therapeutics, Inc.Palvella Therapeutics, Inc.Palvella Therapeutics, Inc.

Palvella Therapeutics, Inc.

No trades
See on Supercharts

PVLA fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no FDA-approved therapies. It develops a pipeline of treatments for rare genetic skin diseases using its patented QTORIN platform. The company was founded in 2015 and is headquartered in Wayne, PA.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
PVLA has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company